rs730880342
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_004985.5(KRAS):c.-29_-28insGGCCAGAGGCTCAGCGGCTC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000594 in 201,926 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00058 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 0 hom. )
Consequence
KRAS
NM_004985.5 5_prime_UTR
NM_004985.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.671
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 12-25250767-G-GGAGCCGCTGAGCCTCTGGCC is Benign according to our data. Variant chr12-25250767-G-GGAGCCGCTGAGCCTCTGGCC is described in ClinVar as [Likely_benign]. Clinvar id is 177929.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00058 (88/151840) while in subpopulation NFE AF= 0.00109 (74/67906). AF 95% confidence interval is 0.00089. There are 0 homozygotes in gnomad4. There are 41 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 88 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRAS | NM_004985.5 | c.-29_-28insGGCCAGAGGCTCAGCGGCTC | 5_prime_UTR_variant | 1/5 | ENST00000311936.8 | NP_004976.2 | ||
KRAS | NM_033360.4 | c.-29_-28insGGCCAGAGGCTCAGCGGCTC | 5_prime_UTR_variant | 1/6 | ENST00000256078.10 | NP_203524.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRAS | ENST00000256078.10 | c.-29_-28insGGCCAGAGGCTCAGCGGCTC | 5_prime_UTR_variant | 1/6 | 1 | NM_033360.4 | ENSP00000256078 | A1 | ||
KRAS | ENST00000311936.8 | c.-29_-28insGGCCAGAGGCTCAGCGGCTC | 5_prime_UTR_variant | 1/5 | 1 | NM_004985.5 | ENSP00000308495 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000580 AC: 88AN: 151840Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
88
AN:
151840
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000639 AC: 32AN: 50086Hom.: 0 Cov.: 0 AF XY: 0.000654 AC XY: 16AN XY: 24466
GnomAD4 exome
AF:
AC:
32
AN:
50086
Hom.:
Cov.:
0
AF XY:
AC XY:
16
AN XY:
24466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000580 AC: 88AN: 151840Hom.: 0 Cov.: 32 AF XY: 0.000553 AC XY: 41AN XY: 74166
GnomAD4 genome
AF:
AC:
88
AN:
151840
Hom.:
Cov.:
32
AF XY:
AC XY:
41
AN XY:
74166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 17, 2012 | -48_-29dup in the 5'UTR of exon 1 of KRAS: The -48_-29dup variant in the KRAS 5' UTR has not been previously reported in the literature. We have identified this variant in one proband and a reportedly unaffected parent in our laboratory. Th e 5' UTR plays a role in the regulation of gene expression and variants in this region have been shown to alter protein translation (Mendell 2001, Scheper 2007) . This type of variant has not been previously reported in an individual with a Noonan spectrum disorder. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at